Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer
February 7, 2017

OPKO Announces U.S. Launch of RAYALDEE™
November 23, 2016

OPKO Presents Data on RAYALDEE® at ASN Kidney Week 2016
November 17, 2016

FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease
June 21, 2016




© 2016 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use